[...]... with heart failure References 1 Hunt SA, Baker DW, Chin MH et al ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary J Heart Lung Transplant 2002;21:189–203 13 2 Leier CV, Dei Cas L, Metra M Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: hyponatremia, hypokalemia, and hypomagnesemia Am Heart. .. Ceresa M et al Cost/utility ratio in chronic heart failure: comparison between heart failure management program delivered by dayhospital and usual care J Am Coll Cardiol 2002; 40:1259–1266 84 Fonarow GC, Stevenson LW, Walden JA et al Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure J Am Coll Cardiol 1997;30:725–732... 2003;41:1510–1518 20 Varadarajan P, Pai RG Prognosis of congestive heart failure in patients with normal versus reduced ejection fractions: results from a cohort of 2,258 hospitalized patients J Card Fail 2003;9:107–112 Heart Failure: Pharmacologic Management Edited by Arthur M Feldman Copyright © 2006 by Blackwell Publishing 1 CHAPTER 1 Diuretics in congestive heart failure Alicia Ross, MD, Ray E Hershberger, MD... periodically While the effectiveness of volume management by heart failure nurses and multidisciplinary heart failure clinics is well established [83–85], this commonly prescribed practice of patient-guided management of diuretics has not been adequately studied [86] Some clinicians in cognitively intact and motivated patients have used this practice in order to prevent heart failure hospitalizations [87]; however,... congestive heart failure in the United States J Am Coll Cardiol 1992;20:301–306 7 McCullough PA, Philbin EF, Spertus JA, Kaatz S, Sandberg KR, Weaver WD Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study J Am Coll Cardiol 2002;39:60–69 8 Lloyd-Jones DM, Larson MG, Leip EP et al Lifetime risk for developing congestive heart failure:. .. Prakash R, Swan HJC Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction N Engl J Med 1973; 288:1087–1090 8 Raftery EB Haemodynamic effects of diuretics in heart failure Br Heart J 1994;72:44–47 9 Kelly DT Vascular effects of diuretics in heart failure Br Heart J 1994;72:48–50 10 Francis GS, Siegel RM, Goldsmith SR, Olivari MT, Levine B, Cohn... Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD) J Am Coll Cardiol 2003;42:705–708 14 Hampton JR Results of clinical trials with diuretics in heart failure Br Heart J 1994;72:68–72 15 Odemuyiwa O, Gilmartin J, Kenny D, Hall RJ Captopril and the diuretic requirements in moderate and severe chronic heart failure Eur Heart J 1989;10:586–590... advancement in the treatment of heart failure? Expert Opin Pharmacother 2004;5:2181–2184 29 Gheorghiade M, Gattis WA, O’Connor CM et al Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial JAMA 2004;291:1963–1971 30 Bayliss J, Norell M, Canepa-Anson R, Sutton G, PooleWilson P Untreated heart failure: clinical and neuroendocrine... refractory congestive heart failure J Card Fail 2004; 10:380–383 79 Latini R, Masson S, Anand I et al Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT) Circulation 2002; 106:2454–2458 80 Murdoch DR, McDonagh TA, Byrne J et al Titration of vasodilator therapy in chronic heart failure according... with heart failure secondary to systolic dysfunction, in whom seminal clinical trials have pointed the way in terms of treatment strategies Introduction However, where appropriate we will point out the potential role for pharmacologic agents in the therapy of patients with heart failure and preserved left ventricular function Despite the advances that have been made in the pharmacologic treatment of heart . y0 w0 h0" alt="" Heart Failure: Pharmacologic Management Dedication to Susan, Emilykate, Elizabeth Willa Heart Failure: Phar macologic Management EDITED. likely due to the diuresis. The vasoconstrictor response to loop 1 Heart Failure: Pharmacologic Management Edited by Arthur M. Feldman Copyright © 2006 by Blackwell